Pakistan's Ambassador to China, Khalil Hashmi, hosted a high-level delegation comprising representatives of 40 leading Chinese pharmaceutical, biotechnology and healthcare companies at the Embassy of Pakistan in Beijing on June 18.
The delegation, led by the China Overseas Development Association, was briefed on investment opportunities in Pakistan ahead of the 6th Pakistan-China B2B Investment Conference on Pharmaceuticals, Biotechnology and Healthcare, scheduled to be held in Karachi on July 17-18, 2026.
Addressing the participants, Ambassador Hashmi highlighted Pakistan’s growing attractiveness as an investment destination and invited Chinese enterprises to participate in the Karachi conference, emphasizing opportunities for industrial cooperation, joint ventures and technology transfer.
A detailed presentation was delivered by Trade and Investment Attaché Ayaz Muhammad, who outlined the potential of Pakistan’s pharmaceutical sector, valued at approximately US$4 billion and growing at an annual rate of 10-12 percent.
The briefing also encouraged mutually beneficial partnerships between Pakistani and Chinese companies in pharmaceuticals, biotechnology and healthcare, with a focus on expanding investment, local production and technology collaboration.
Earlier, Pakistan and China took another step forward in deepening their pharmaceutical and healthcare ties today, as top diplomats and industry leaders gathered in Beijing to rally Chinese enterprises ahead of a major investment conference planned for Karachi next month.
The China-Pakistan Pharmaceutical, Healthcare and Biotechnology Business Briefing, jointly organized by the Embassy of Pakistan and the China Industry Overseas Development Association (CODA), drew over 40 companies covering everything from biopharmaceuticals and API manufacturing to medical devices and biotechnology.
